Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 106

Results For "VAI"

1903 News Found

GSK’s new data underscore important responses with momelotinib for myelofibrosis patients
Clinical Trials | December 12, 2022

GSK’s new data underscore important responses with momelotinib for myelofibrosis patients

48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response


Global pacemakers market set to grow at 5.4% CAGR over next 3 years: GlobalData
News | December 12, 2022

Global pacemakers market set to grow at 5.4% CAGR over next 3 years: GlobalData

GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.


World Ayurveda Congress and Arogya Expo 2022 inaugurated in Goa
News | December 09, 2022

World Ayurveda Congress and Arogya Expo 2022 inaugurated in Goa

The 9th World Ayurveda Congress and Arogya Expo 2022 aims to showcase the efficacy and strength of the AYUSH systems of medicine at the global level


Aster DM Healthcare and Faruk Medical City to develop healthcare services in Iraq
Healthcare | December 08, 2022

Aster DM Healthcare and Faruk Medical City to develop healthcare services in Iraq

Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff


Modi to dedicate three National Ayush Institutes to the nation on Dec 11
Policy | December 08, 2022

Modi to dedicate three National Ayush Institutes to the nation on Dec 11

These satellite institutes will further strengthen the research, international collaborations and facilitate affordable Ayush services for the larger community.


Telemedicine service eSanjeevani achieves 8 crore teleconsultations
News | December 07, 2022

Telemedicine service eSanjeevani achieves 8 crore teleconsultations

The initiative has garnered the distinction of being the world’s largest government owned telemedicine platform


BASF Pharma Solutions excipient accepted into FDA Pilot Program
Drug Approval | December 06, 2022

BASF Pharma Solutions excipient accepted into FDA Pilot Program

Soluplus branded excipient play a critical role in enabling the drug development process for poorly soluble active pharmaceutical ingredients


JB Pharma reduces price of Azmarda by 50%
News | December 06, 2022

JB Pharma reduces price of Azmarda by 50%

Move to increase affordability and accessibility for heart failure patients across the country


WuXi STA launches parenteral formulation manufacturing line at Wuxi
News | December 01, 2022

WuXi STA launches parenteral formulation manufacturing line at Wuxi

This is the second line opened this year for parenteral drug product clinical and commercial manufacturing, with an annual capacity of 10 million units